Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

Delayed Quote. Delayed  - 06/30 10:01:26 pm
61.91 USD   +0.16%
08:28p ABBVIE : 's HUMIRA® (adalimumab) Receives U.S. Food and Drug Adminis..
06/20 Novartis aims to triple biosimilar drugs by 2020
06/16 ABBVIE : Declares Quarterly Dividend
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/24/2016 06/27/2016 06/28/2016 06/29/2016 06/30/2016 Date
59.86(c) 58.68(c) 59.99(c) 61.81(c) 61.91(c) Last
9 878 541 7 947 017 9 897 585 9 308 022 7 920 605 Volume
-2.37% -1.97% +2.23% +3.03% +0.16% Change
More quotes
Financials ($)
Sales 2016 25 506 M
EBIT 2016 10 723 M
Net income 2016 6 670 M
Debt 2016 28 261 M
Yield 2016 3,64%
Sales 2017 27 981 M
EBIT 2017 12 278 M
Net income 2017 8 226 M
Debt 2017 25 726 M
Yield 2017 3,98%
P/E ratio 2016 14,95
P/E ratio 2017 11,86
EV / Sales2016 5,03x
EV / Sales2017 4,49x
Capitalization 99 969 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and... 
Sector
Pharmaceuticals
Calendar
07/13Ex-dividend day
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
08:28p ABBVIE : 's HUMIRA® (adalimumab) Receives U.S. Food and Drug Administration Appr..
06/23 INFINITY PHARMACEUTICALS : Reports Topline Results From DYNAMO, A Phase 2 Monoth..
06/23 ABBVIE : Study Findings on Pharmacology Are Outlined in Reports from AbbVie Inc...
06/23 ABBVIE : Researchers from AbbVie Inc. Discuss Findings in Rheumatoid Arthritis (..
06/20 Novartis aims to triple biosimilar drugs by 2020
06/16 ABBVIE : Declares Quarterly Dividend
06/09 ABBVIE : Investigators at AbbVie Inc. Report Findings in Rheumatoid Arthritis (D..
06/08 ABBVIE INC. : Temporary Suspension of Trading Under Registrant's Employee Benefi..
06/07 ABBVIE : shares fall on low survival data for lung cancer drug
06/06 Chesapeake Energy, Devon and Ciber climb, AbbVie slips
More news
Sector news : Specialty & Advanced Pharmaceuticals
01:41pDJSHIRE : Files 8K - Other Events
07:59aDJGLAXOSMITHKLINE : Starts Phase-1 for Antibody Clinical Trial
02:51aDJMONSANTO : Shops Around For 'Right Combination' -- WSJ
06/29DJSHANGHAI FOSUN PHARMACEUTICAL () : Approves Listing of 66.2%-Owned Sisram Medica..
06/29DJSHIRE : Correction to Story on Shire's ADHD Drug
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
News from SeekingAlpha
07:42p Recent Stock Purchase II June 2016
09:40a Expect OraSure To Drop 35% (Or More) Next Week
06/29 Job Cuts Continue
06/29 FDA granted Ibrutinib breakthrough therapy designation for the development of..
06/29 Brexit Analysis - Top 10 U.K. Drugs
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions